RT Book, Section
A1 McQuaid, Kenneth R.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
SR Print(0)
ID 1175802346
T1 Intestinal Motility Disorders
T2 Current Medical Diagnosis & Treatment 2021
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260469868
LK accessmedicine.mhmedical.com/content.aspx?aid=1175802346
RD 2023/06/09
AB Key  Clinical  Updates  in  Intestinal  Motility  DisordersIn  2019,  a  small  blinded  crossover  trial  of  34  patients  with  confirmed  gastroparesis,  the  serotonin  5-HT4  receptor  agonist,  prucalopride  (currently  FDA  approved  for  treatment  of  chronic  constipation)  demonstrated  significant  improvement  in  gastric  emptying  and  symptoms  compared  with  placebo.